Real-World, Observational Study Assessing The Proportion Of Leukapheresed Patients with Relapsed and Refractory Multiple Myeloma That Receive Infusion of Idecabtagene Vicleucel (CA089-1097) First published 21/02/2025 Last updated 21/02/2025 EU PAS number:EUPAS1000000456 Study Planned